National Research Corporation (NRC)
Company Info
Highlights
$295.98M
$1.02
12.74
$141.30M
$82.11M
$41.21M
$12.39 - $13.75
13.81%
4.22
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
NRC
N/A
N/A
N/A
N/A
N/A
N/A
^GSPC (Benchmark)
-3.77%
5.53%
-5.60%
8.37%
14.61%
10.35%
Monthly Returns
The table below presents the monthly returns of NRC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 1.64% | 1.64% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of NRC is 4, meaning it’s performing worse than 96% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for National Research Corporation (NRC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
National Research Corporation provided a 3.70% dividend yield over the last twelve months, with an annual payout of $0.48 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.48 | $0.48 | $1.48 | $0.84 | $0.48 | $0.21 | $0.78 | $1.13 | $0.40 | $0.34 | $0.62 | $0.06 |
Dividend yield | 3.70% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Monthly Dividends
The table displays the monthly dividend distributions for National Research Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.12 | $0.00 | $0.12 | ||||||||||
| 2024 | $0.12 | $0.12 | $0.12 | $0.12 | $0.48 | ||||||||
| 2023 | $0.12 | $0.12 | $1.12 | $0.12 | $1.48 | ||||||||
| 2022 | $0.24 | $0.24 | $0.24 | $0.12 | $0.84 | ||||||||
| 2021 | $0.12 | $0.12 | $0.12 | $0.12 | $0.48 | ||||||||
| 2020 | $0.21 | $0.21 | |||||||||||
| 2019 | $0.19 | $0.19 | $0.19 | $0.21 | $0.78 | ||||||||
| 2018 | $0.10 | $0.17 | $0.17 | $0.69 | $1.13 | ||||||||
| 2017 | $0.10 | $0.10 | $0.10 | $0.10 | $0.40 | ||||||||
| 2016 | $0.08 | $0.08 | $0.08 | $0.10 | $0.34 | ||||||||
| 2015 | $0.06 | $0.06 | $0.06 | $0.44 | $0.62 | ||||||||
| 2014 | $0.06 | $0.06 |
Dividend Yield & Payout
Dividend Yield
National Research Corporation has a dividend yield of 3.70%, which is quite average when compared to the overall market.
Payout Ratio
National Research Corporation has a payout ratio of 61.66%, which is quite average when compared to the overall market. This suggests that National Research Corporation strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the National Research Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the National Research Corporation was 3.20%, occurring on May 9, 2025. The portfolio has not yet recovered.
The current National Research Corporation drawdown is 3.20%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -3.2% | May 9, 2025 | 1 | May 9, 2025 | — | — | — |
| -0.7% | May 6, 2025 | 1 | May 6, 2025 | 1 | May 7, 2025 | 2 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of National Research Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of National Research Corporation, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 13.3% positive surprise.
Valuation
The Valuation section provides an overview of how National Research Corporation is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for NRC, comparing it with other companies in the Diagnostics & Research industry. Currently, NRC has a P/E ratio of 12.7. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for NRC relative to other companies in the Diagnostics & Research industry. Currently, NRC has a P/S ratio of 2.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for NRC in comparison with other companies in the Diagnostics & Research industry. Currently, NRC has a P/B value of 10.0. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |